LifeHealthcare Group Limited (ASX:LHC)
Managing Director & CEO, Daren McKennay presents at the ASX Investor Series in Sydney
LifeHealthcare Group was formed in 2006 and is now a leading Australian and New Zealand medical device supplier.
The presentation covers the company's unique offering and its strategy to benefit from growing demand for sophisticated medical procedures.
Speaking about the medical device sector Mr McKennay says, "We apply a value added business model to the sector which really differentiates us from the incumbent players in that market which were traditionally branch offices of large multinationals."
"We have seen growth from revenue, profit and cash flow perspectives since 2006."
"When we think about the business we think about it across three primary product segments, this gives you a sense of the size and scale of the business and how its split. Implantable devices, such as a knee replacement. Non-implantable devices which roughly represent about 13 per cent of our business, these are typically consumable devices that are used with implants or with capital equipment. And then we do high end capital equipment so these are very complex pieces of capital equipment."
"From a growth perspective we're really focused on spine/neuro surgery, orthopedics and cardiology. Spine and neuro is where we started first back in 2006. We're now the number three player in the market and we can see the way to the number two spot in the short to medium term."
"The guidance we're giving is that we see revenue growth rates in the low double digit range."